Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22579160 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
Condition: Schizophrenia
Interventions: Drug: Oral risperidone;   Drug: Risperidone Long-Acting Injection (RLAI)

Indicates status has not been verified in more than two years